Contraceptive practices in women with sickle-cell disease

References

• Al Kahtani MA, AlQahtani M, Alshebaily MM, Abd Elzaher M, Moawad A, Aljohani N. 2012. Morbidity and pregnancy outcomes associated with sickle cell anaemia among Saudi women. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 119:224–226.
   PubMed Web of Science ®Google Scholar
• Austin H, Lally C, Benson JM, Whitsett C, Hooper WC, Key NS. 2009. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. American Journal of Obstetrics and Gynecology 200:620.e1–623.
   PubMed Web of Science ®Google Scholar
• Balgir RS. 1994. Age at menarche and first conception in sickle cell hemoglobinopathy. Indian Pediatrics 31:827–832.
   PubMedGoogle Scholar
• Cançado RD, Jesus JA. 2007. A doença falciforme no Brasil. Revista Brasileira de Hematologia e Hemoterapia 29:203–206.
   Google Scholar
• De Abood M, de Castillo Z, Guerrero F, Espino M, Austin KL. 1997. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients. Contraception 56:313–316.
   PubMed Web of Science ®Google Scholar
• De Ceulaer K, Gruber C, Hayes R, Serjeant GR. 1982. Medroxyprogesterone acetate and homozygous sickle-cell disease. Lancet 2:229–231.
   PubMed Web of Science ®Google Scholar
• Dauphin-McKenzie N, Gilles JM, Jacques E, Harrington T. 2006. Sickle cell anaemia in the female patient. Obstetrical & Gynecological Survey 61:343–352.
   PubMed Web of Science ®Google Scholar
• Haddad LB, Curtis KM, Legardy-Williams JK, Cwiak C, Jamieson DJ. 2012. Contraception for individuals with sickle cell disease: a systematic review of the literature. Contraception 85:527–537.
   PubMed Web of Science ®Google Scholar
• Hamideh D, Alvarez O. 2013. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer 60:1482–1486.
   PubMed Web of Science ®Google Scholar
• Hassell KL. 2010. Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine 38:S512–S521.
   PubMed Web of Science ®Google Scholar
• Howard RJ, Lillis C, Tuck SM. 1993. Contraceptives, counselling, and pregnancy in women with sickle cell disease. BMJ (Clinical Research Ed.) 306:1735–1737.
   PubMed Web of Science ®Google Scholar
• Isaacs WA, Effiong CE, Ayeni O. 1972. Steroid treatment in the prevention of painful episodes in sickle-cell disease. Lancet 1:570–571.
   PubMed Web of Science ®Google Scholar
• Knight-Madden J, Barton-Gooden A. 2009. Contraceptive usage among Jamaican women with sickle cell disease. Contraception 80:474–478.
   PubMed Web of Science ®Google Scholar
• Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, et al. 2008. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Annals of Internal Medicine 148:939–955.
   PubMed Web of Science ®Google Scholar
• M’Pemba-Loufoua AB, Nzingoula S, Moubouh-Akouala F, Oba A. 2001. [Pubertal development in girls with homozygote sickle cell disease. Apropos of 72 cases]. Bulletin de la Société de Pathologie Exotique (1990) 94:326–329.
   PubMed Web of Science ®Google Scholar
• Manchikanti A, Grimes DA, Lopez LM, Schulz KF. 2007. Steroid hormones for contraception in women with sickle cell disease. The Cochrane Database of Systematic Reviews CD006261.
   PubMed Web of Science ®Google Scholar
• Ministerio da Saude (Brasil). 2006. Pesquisa Nacional de Demografia e Saúde da Criança e da Mulher PNDS 2006,
   Google Scholar
• Ministerio da Saude (Brasil). 2008. Programa de Atenção integral às pessoas com Doenças falciformes e OuTRAS hemoglobinopatias da cidade de São Paulo ministério da Saúde Governo federal agradecimentos As discussões que envolveram a produção do presente documento iniciaram-se no ano de 2005 [Internet]. Available from: http://ww2. prefeitura.sp.gov.br/arquivos/secretarias/saude/popnegra/DoencaFalciforme_ProgramaAtencaoIntegral.pdf [last accessed 2014 May 16].
   Google Scholar
• National Institutes of Health, National Heart, Lung, and Blood Institute, and Division of Blood Diseases and Resources. The management of sickle cell disease (NIH Publication No. 02-2117), 4th edition. Bethesda, MD: NIH; 2002. Available from: http://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf [last accessed Jan 2016].
   Google Scholar
• O’Brien SH, Klima J, Reed S, Chisolm D, Schwarz EB, Kelleher KJ. 2011. Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims. Contraception 83:134–137.
   PubMed Web of Science ®Google Scholar
• Platt OS, Rosenstock W, Espeland MA. 1984. Influence of sickle hemoglobinopathies on growth and development. The New England Journal of Medicine 311:7–12.
   PubMed Web of Science ®Google Scholar
• Rajab KE, Issa AA, Mohammed AM, Ajami AA. 2006. Sickle cell disease and pregnancy in Bahrain. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 93:171–175.
   PubMed Web of Science ®Google Scholar
• Samuels-Reid JH, Scott RB, Brown WE. 1984. Contraceptive practises and reproductive patterns in sickle cell disease. Journal of the National Medical Association 76:879–883.
   PubMed Web of Science ®Google Scholar
• Serjeant GR, Loy LL, Crowther M, Hambleton IR, Thame M. 2004. Outcome of pregnancy in homozygous sickle cell disease. Obstetrics and Gynecology 103:1278–1285.
   PubMed Web of Science ®Google Scholar
• Singhal A, Thomas P, Cook R, Wierenga K, Serjeant G. 1994. Delayed adolescent growth in homozygous sickle cell disease. Archives of Disease in Childhood 71:404–408.
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. 2003. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anaemia: risks and benefits up to 9 years of treatment. JAMA: The Journal of the American Medical Association 289:1645–1651.
   PubMed Web of Science ®Google Scholar
• Villers MS, Jamison MG, De Castro LM, James AH. 2008. Morbidity associated with sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology 199:125.e1–125.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. 2009. Medical elegibility criteria for contraceptive use [Internet]. Available from: http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf [last accessed 2014 May 16].
   Google Scholar
• Yoong WC, Tuck SM, Yardumian A. 1998. The effect of ovarian steroids on sickle cell deformability. Clinical and Laboratory Haematology 20:151–154.
   PubMedGoogle Scholar